Which antibodies did the previous MSD formulation of measles, mumps and rubella vaccine (live) induce in studies of seronegative children?

In 284 triple-seronegative children aged 11 months–7 years, one injection of the previous MSD measles, mumps and rubella vaccine (live) formulation induced measles haemagglutination-inhibition antibodies in 95%, mumps neutralising antibodies in 96%, and rubella haemagglutination-inhibition antibodies in 99% of susceptible persons.